2023
The effect of 12-month postoperative weight change on outcomes following midurethral sling for stress urinary incontinence: a secondary analysis of the ESTEEM and TOMUS randomized trials
Getaneh F, Ringel N, Kolm P, Iglesia C, Dieter A. The effect of 12-month postoperative weight change on outcomes following midurethral sling for stress urinary incontinence: a secondary analysis of the ESTEEM and TOMUS randomized trials. International Urogynecology Journal 2023, 34: 2809-2816. PMID: 37750917, DOI: 10.1007/s00192-023-05654-7.Peer-Reviewed Original ResearchConceptsMixed urinary incontinenceStress urinary incontinencePostoperative weight changeMidurethral slingUrinary incontinenceSUI curePrimary outcomeUUI episodesWeight changeBody weightHigher baseline body mass indexTreatment of SUISecondary analysisBaseline body mass indexWeight gainWeight lossSUI cure ratesMulticenter Randomized TrialImpact of obesityBody mass indexHigh smoking ratesMethodsThis secondary analysisGreater improvementMUS placementPerioperative variables
2022
Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial
Chang E, Ringel N, Woodburn K, Tanner J, Bassaly R, Greene K, Wyman A, Iglesia C. Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial. Urogynecology 2022, 28: 518-525. PMID: 35543540, DOI: 10.1097/spv.0000000000001199.Peer-Reviewed Original ResearchMeSH KeywordsBotulinum Toxins, Type AHumansInjections, IntramuscularPain, ProceduralTreatment OutcomeUrinary Bladder, OveractiveUrinary IncontinenceConceptsUrgency urinary incontinenceOveractive bladderProcedure timeIntradetrusor injectionsAdverse eventsUrinary incontinenceClinical trialsSubjective efficacyAverage pain scoreGlobal response assessmentRefractory overactive bladderIdiopathic overactive bladderVisual analog scalePain scoresOnabotulinumtoxinA treatmentPain AssociatedPain levelsWeeks postprocedurePostprocedure complicationsAnalog scaleProcedure durationResponse assessmentPatient experiencePatientsInjection paradigm
2021
Surgical Outcomes in Urogynecology—Assessment of Perioperative and Postoperative Complications Relative to Preoperative Hemoglobin A1c—A Fellows Pelvic Research Network Study
Ringel NE, de Winter KL, Siddique M, Marczak T, Kisby C, Rutledge E, Soriano A, Samimi P, Schroeder M, Handler S, Zeymo A, Gutman RE. Surgical Outcomes in Urogynecology—Assessment of Perioperative and Postoperative Complications Relative to Preoperative Hemoglobin A1c—A Fellows Pelvic Research Network Study. Urogynecology 2021, 28: 7-13. PMID: 33886510, DOI: 10.1097/spv.0000000000001057.Peer-Reviewed Original ResearchMeSH KeywordsFemaleGlycated HemoglobinHumansPostoperative ComplicationsRetrospective StudiesRisk FactorsTreatment OutcomeConceptsPelvic reconstructive surgeryMultivariate logistic regressionPostoperative complicationsOverall complicationsSevere complicationsReconstructive surgeryMulticenter retrospective cohort studyLogistic regressionUrinary incontinence surgeryRetrospective cohort studyResearch Network StudyFemale pelvic medicineReconstructive surgery programsHbA1c thresholdPreoperative HbA1cPreoperative hemoglobinUrogynecology populationAverage HbA1cIncontinence surgeryCohort studyMesh exposureDiabetes mellitusDiabetic patientsSurgery typeDiabetic cohort